PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ranjan, T; Desjardins, A; Peters, KB; Alderson, L; Kirkpatrick, J; Herndon, J; Bailey, L; Sampson, J; Friedman, AH; Friedman, H; Vredenburgh, JJ

Published Date

  • October 1, 2012

Published In

Volume / Issue

  • 14 /

Start / End Page

  • 79 - 79

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

Conference Location

  • Washington, DC

Conference Start Date

  • November 15, 2012

Conference End Date

  • November 18, 2012